0001209191-20-046372.txt : 20200812
0001209191-20-046372.hdr.sgml : 20200812
20200812163059
ACCESSION NUMBER: 0001209191-20-046372
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200811
FILED AS OF DATE: 20200812
DATE AS OF CHANGE: 20200812
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BERQUIST JOSEPH A
CENTRAL INDEX KEY: 0001487224
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12019
FILM NUMBER: 201095817
MAIL ADDRESS:
STREET 1: QUAKER CHEMICAL CORPORATION
STREET 2: ONE QUAKER PARK, 901 E. HECTOR STREET
CITY: CONSHOHOCKEN
STATE: PA
ZIP: 19428-2380
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUAKER CHEMICAL CORP
CENTRAL INDEX KEY: 0000081362
STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS PRODUCTS OF PETROLEUM & COAL [2990]
IRS NUMBER: 230993790
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE QUAKER PARK
STREET 2: 901 HECTOR STREET
CITY: CONSHOHOCKEN
STATE: PA
ZIP: 19428
BUSINESS PHONE: 6108324000
MAIL ADDRESS:
STREET 1: ONE QUAKER PARK
STREET 2: 901 HECTOR ST
CITY: CONSHOHOCKEN
STATE: PA
ZIP: 19428
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-11
0
0000081362
QUAKER CHEMICAL CORP
KWR
0001487224
BERQUIST JOSEPH A
ONE QUAKER PARK
901 E. HECTOR STREET
CONSHOHOCKEN
PA
19428-2380
0
1
0
0
SVP, GL SPEC BUS & CSO
Common Stock
2020-08-11
4
M
0
2188
134.60
A
14703
D
Common Stock
2020-08-11
4
S
0
1988
201.97
D
12715
D
Common Stock
2020-08-11
4
S
0
200
202.61
D
12515
D
Common Stock
2020-08-11
4
M
0
1660
151.75
A
14175
D
Common Stock
2020-08-11
4
S
0
1188
201.75
D
12987
D
Common Stock
2020-08-11
4
S
0
472
202.68
D
12515
D
Common Stock
1596
I
By 401(k)
Employee Stock Option (right to buy)
134.60
2020-08-11
4
M
0
2188
0.00
D
2024-02-27
Common Stock
2188
0
D
Employee Stock Option (right to buy)
151.75
2020-08-11
4
M
0
1660
0.00
D
2025-02-26
Common Stock
1660
830
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.42 to $202.41, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.575 to $202.635, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.14 to $202.13, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.41 to $203.085, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.
Information based on reporting person's Plan statement as of June 30, 2020.
The options for this grant vested in three annual installments: 730 shares on February 27, 2018; 729 shares on February 27, 2019; and 729 shares on February 27, 2020.
The options for this grant vest in three annual installments: 830 shares on February 26, 2019; 830 shares on February 26, 2020; and 830 shares on February 26, 2021.
Victoria K. Gehris, Attorney-in-Fact for Joseph A. Berquist
2020-08-12